2seventy bio, Inc.
TSVT
$4.98
$0.010.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -78.38% | 50.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -78.38% | 50.93% | |||
| Cost of Revenue | 24.19% | -27.63% | |||
| Gross Profit | -2,529.96% | 94.72% | |||
| SG&A Expenses | -33.84% | 30.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.53% | -8.02% | |||
| Operating Income | -71.86% | 33.99% | |||
| Income Before Tax | -96.52% | -139.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -96.52% | -139.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -96.52% | -139.93% | |||
| EBIT | -71.86% | 33.99% | |||
| EBITDA | -81.99% | 36.94% | |||
| EPS Basic | -96.21% | -139.88% | |||
| Normalized Basic EPS | -104.88% | 42.57% | |||
| EPS Diluted | -96.21% | -142.24% | |||
| Normalized Diluted EPS | -104.88% | 39.45% | |||
| Average Basic Shares Outstanding | 0.14% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.14% | -5.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||